动脉样硬化治疗中的QingRe HuoXue公式的机制:使用生物信息学,机器学习和实验验证的综合方法
Guiting Zhou1, Zhichao Lin2, Qing Miao2
1Department of Cardiology, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China; First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
International immunopharmacology
|August 13, 2024
概括
青瑞黄配方 (QRHXF) 通过上调COL1A1表达,促进斑块稳定性,有效治疗动脉样硬化. 这项研究揭示了QRHXFF.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 是导致心血管疾病的主要原因之一.
- 青瑞黄素配方 (QRHXF) 是一种用于AS治疗的中国传统医药.
- 在AS中QRHXF的精确机制仍然不完全理解.
研究的目的:
- 评估QRHXF对AS的治疗疗效.
- 阐明QRHXF在AS中的作用背后的药理机制.
主要方法:
- 网络药理学和机器学习以识别候选基因.
- 分子对接以评估化合物-基因相互作用.
- 转录组分析和动物实验 (APOE-/-小鼠) 用于验证.
- 定量PCR (qPCR) 用于确认基因表达水平.
主要成果:
- 通过网络药理学和机器学习,确定了10个潜在的治疗基因,包括COL1A1和CCR7.
- 通过分子对接,证实了QRHXF活性化合物与目标基因之间的良好的结合亲和力.
- 转录组分析显示,COL1A1和CCR7是AS的关键基因.
- 在小鼠模型中,QRHXF治疗减少了大动脉斑块的形成,并改善了血脂水平.
- QRHXF显著上调了COL1A1mRNA的表达,增强了斑块纤维化和稳定性.
结论:
- 对AS的QRHXF治疗涉及对炎症和免疫路径的调节.
- 转录组测序和实验验证证证了QRHXF在促进COL1A1表达中的作用.
- QRHXF通过增加COL1A1表达和纤维化来增强AS斑块的稳定性.
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...